Prot #EFC17801: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Study, Followed by Open-Label Extensions, to Evaluate the Efficacy of Oral Belumosudil in Adult Participants with Chronic Lung Allograft Dysfunction

Project: Research project

Project Details

StatusActive
Effective start/end date1/19/241/19/27

Funding

  • ICON Clinical Research, LLC (Prot #EFC17801 AMD 1 // Prot #EFC17801 AMD 1)
  • Sanofi US Services Inc. (Prot #EFC17801 AMD 1 // Prot #EFC17801 AMD 1)